The Service Line
Monday is the day three open questions in this week’s coverage either close or start to bite, and in each one the operator still has a say. Five Service Line deep dives ran this week, from nephrology on Monday to pharmacy on Saturday. Tuesday’s radiology issue did not publish, so we cover that gap below. These are the five items a cross-specialty operator must not have missed, each re-checked against a source this run where we could, plus one connective insight. Confidence is stated per item.
Pharmacies and Part D plans: the comment window on what a “reasonable” network contract means closes Monday
The Centers for Medicare & Medicaid Services (CMS) request for information on pharmacy network terms, CMS-4217-NC in the Federal Register, closes for comment November 23. It is the first step toward defining the “reasonable and relevant” terms Part D plans must offer any willing pharmacy from January 1, 2029, with standards due from the Secretary by April 2028. Per Reed Smith and Becker’s Hospital Review, CMS asks about dispensing fees against real costs, network contracting practices, quality measures and plan audits. Frier Levitt reports CMS discourages identical template comments, so specific contract data carries more weight. Independent pharmacy owners and the groups that negotiate for them should file this weekend, and every plan and pharmacy benefit manager should expect the record to be read. We did not confirm the electronic filing channel from these sources, so check the notice. Confidence: High on the November 23 close; Low on where CMS lands, since this is an information request only.
Behavioral health and telehealth prescribers: the White House review clock on the DEA rule runs out Monday, and December 31 is 39 days away
The Drug Enforcement Administration’s final rule on special registration for telemedicine prescribing of controlled substances went to the Office of Information and Regulatory Affairs (OIRA) on August 25, per Frier Levitt. A standard 90 days from that date lands on Monday, November 23, with one 30-day extension possible into late December. No rule text is public and we found no sign it has published or been extended. The current prescribing flexibilities expire December 31, and it is not yet known whether the final rule keeps the platform registration idea from the January 2025 proposal. Any virtual-first psychiatry, buprenorphine or stimulant program needs a written Plan B for January 1 and a daily check of the Federal Register. This continues our November 12 and 15 coverage. Confidence: High that the rule is pending; Low on whether it publishes before the cliff.
Every specialty: the 2027 rules cut the conversion factor to about $32.63, and for imaging the hospital side gets a site-neutral cut
The 2027 conversion factor, the dollar multiplier on every relative value unit, is down 2.31 percent for most clinicians and 1.83 percent for advanced payment model participants, per the American College of Radiology (ACR), after a one-time 2.5 percent bump expired. Radiology Business reports the companion outpatient rule pays the physician fee schedule rate, not the hospital rate, for some services in non-contrast imaging payment groups 5521 to 5524, which cover certain X-rays, ultrasounds, CT and MRI. That is the radiology item our missing Tuesday issue would have carried. Outlets disagree on the qualifying-model percentage, and ACR says its code-level tables are still being recalculated, so run your own top codes at the final factor. Reprice compensation models now. Confidence: High on the conversion factor direction; Medium on which hospital imaging services the site-neutral payment reaches, since we did not open the rule tables.
Home health and hospice: the freeze is extended, but only for new agencies
CMS extended the nationwide moratoria on new Medicare hospice and home health agency enrollment for six more months, effective November 12, per McGuireWoods, which reports an end date of May 12, 2027. The Federal Register notices are home health and hospice. The extension now applies only to initially enrolling agencies, so existing ones can add locations, and Home Health Care News reports agencies can resubmit location applications that were denied. We read the law-firm and trade summaries, not the notice text, so confirm the end date there. This is the first of the two outcomes we told readers to plan for. Confidence: High on the extension and the narrowing; Medium on the exact end date.
Surgery centers: the $25 deal stands, and nothing has closed it
Surgery Partners amended its merger with HealthSpan Partners, an affiliate of the nonprofit system Bon Secours Mercy Health, to $25.00 a share in cash after an unsolicited $28.00 proposal arrived November 3, per the company’s November 9 8-K exhibit. The board called the rival offer not superior on closing timeline and regulatory risk, and Bain Capital, with about 39 percent, agreed to vote in favor. Becker’s, citing Bloomberg, identified the rival as UnitedHealth Group; the company has not. The company’s third-quarter release still targets a first-quarter 2027 close, and we found no stockholder meeting date or vote result. For surgeon-owners, the deal is a reminder that bidders pay for regulatory speed. Confidence: High on terms; Low on the bidder’s identity.
Also on the watch list
We did not re-verify the measles elimination, labor and delivery closure and 340B items from earlier this week this run, so we are not restating figures. They remain open threads in the daily editions.
Connective tissue: the calendar is the strategy this week
Read the week by its dates. Monday brings the pharmacy comment close and the end of the standard White House review window for the telemedicine rule. December 31 ends the prescribing flexibilities. January 1 resets every conversion factor and outpatient rate, and the surgery center deal is built to close in the first quarter. The pattern is that the rules operators most need, a definition of a fair pharmacy contract and the telemedicine registration, are still unwritten, and unwritten rules are where comment and planning pay off, while the written ones, the 2027 payment cuts, only reward repricing. The practical move is to spend this week on the two open files and the next on the repricing. Confidence: Medium, our synthesis of the sourced items above, not a sourced finding.
Dates Ahead
- November 23: Part D pharmacy contract request for information closes; the standard 90-day OIRA review mark on the DEA telemedicine rule.
- December 31: current DEA telemedicine prescribing flexibilities expire.
- January 1, 2027: 2027 Medicare payment rates take effect.
- First quarter 2027: Surgery Partners closing target.
- May 12, 2027: reported end of the hospice and home health moratoria.
Free. One email a day at 6pm your time, or one summary every Friday. Switch or stop anytime.